roles of nicotine on Ca 2ϩ oscillations [intracellular Ca 2ϩ ([Ca 2ϩ ]i) oscillation] in rat primary cultured cortical neurons were studied. The spontaneous [Ca 2ϩ ]i oscillations (SCO) were recorded in a portion of the neurons (65%) cultured for 7-10 days in vitro. Application of nicotine enhanced [Ca 2ϩ ]i oscillation frequency and amplitude, which were reduced by the selective ␣4␤2-nicotinic acetylcholine receptors (nAChRs) antagonist dihydro-␤-erythroidine (DH␤E) hydrobromide, and the selective ␣7-nAChRs antagonist methyllycaconitine citrate (MLA, 20 nM). DH␤E reduced SCO frequency and prevented the nicotinic increase in the frequency. DH␤E somewhat enhanced SCO amplitude and prevented nicotinic increase in the amplitude. MLA (20 nM) itself reduced SCO frequency without affecting the amplitude but blocked nicotinic increase in [Ca 2ϩ ]i oscillation frequency and amplitude. Furthermore, coadministration of both ␣ 4␤2-and ␣7-nAChRs antagonists completely prevented nicotinic increment in [Ca 2ϩ ]i oscillation frequency and amplitude. Thus, our results indicate that both ␣ 4␤2-and ␣7-nAChRs mediated nicotine-induced [Ca 2ϩ ]i oscillations, and two nAChR subtypes differentially regulated SCO. intracellular calcium ion concentration oscillations; nicotine; ␣4␤2-nicotinic acetylcholine receptors; ␣7-nicotinic acetylcholine receptors; calcium NICOTINIC ACETYLCHOLINE RECEPTORS (nAChRs) mediate the excitability of neuronal circuits related to the memory, motivation, and mood (15, 16), are reduced in neurodegenerative and neuropsychiatric disorders such as schizophrenia and Alzheimer's disease (6, 22, 24) , and have been proposed as potential therapeutic targets for these diseases (13, 28) .
NICOTINIC ACETYLCHOLINE RECEPTORS (nAChRs) mediate the excitability of neuronal circuits related to the memory, motivation, and mood (15, 16) , are reduced in neurodegenerative and neuropsychiatric disorders such as schizophrenia and Alzheimer's disease (6, 22, 24) , and have been proposed as potential therapeutic targets for these diseases (13, 28) .
At least four different nAChR subtypes, non-␣ 7 (␣ 2 , ␣ 3 ␤ 4 , ␣ 4 ␤ 2 )-and ␣ 7 -nAChRs, are expressed in the cortex. The most commonly expressed nAChR subtype is the ␣ 4 ␤ 2 -receptor (90%), which is characterized by its high affinity for acetylcholine (ACh) and nicotinic agonists (10, 30) .
Calcium (Ca 2ϩ ) signaling mediates numerous cellular responses, including neurotransmitter release and mitochondrial function (34) . Intracellular Ca 2ϩ ([Ca 2ϩ ] i ) oscillations are associated with bursts of action potentials (21) and result from spontaneous and synchronous neural activities in neural networks (19) . The spontaneous [Ca 2ϩ ] i oscillations (SCO) can be recorded in many cell types, including neocortical, hippocampal, cerebellar neurons, and stratum lucidum region astrocytes (1, 4, 12, 20) . [Ca 2ϩ ] i oscillations in neurons can be triggered by ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation and mediated by Ca 2ϩ release from [Ca 2ϩ ] i stores induced by metabotropic glutamate receptor signaling (5) . The [Ca 2ϩ ] i oscillations are implicated in the regulation of neural plasticity (3, 26) , which may be related to the increased efficiency and specificity of gene expression. Studies show both oscillation amplitude and frequency are critical for the regulation of gene expression and transcription (14, 25) .
Although it has been reported that activation of nAChRs induces [Ca 2ϩ ] i oscillations, which is mediated by Ca 2ϩ influx and melatonin release from pinealocytes (17) , the effect of nicotine on [Ca 2ϩ ] i oscillations in cortical neurons has not been reported. In this study, we investigated the nicotinic modulation of [Ca 2ϩ ] i oscillations in rat cortical neurons in primary culture and found that nicotinic enhancement of the oscillatory Ca 2ϩ signals is mediated through both ␣ 4 ␤ 2 -and ␣ 7 -nAChRs.
MATERIALS AND METHODS

Cortical neuronal cultures.
Primary cultures of cortical neurons were prepared from 17-to 18-day-old Sprague-Dawley rat embryos as described previously (14a) . All cell culture reagents were purchased from Invitrogen (Grand Island, NY) and Sigma Aldrich (St. Louis, MO). Cells were plated in 35-mm culture dishes pretreated with 25 g/ml poly-D-lysine in PBS and cultured for 7-10 days in vitro in Neurobasal medium supplemented with 2% (vol/vol) B-27 medium and 1 mM GluMAX and 100 U/ml penicillin at 37°C in 95% oxygen and 5% CO 2 atmosphere. Ca 2ϩ imaging. Intracellular Ca 2ϩ concentration in the cultured cortical neurons was measured using the membrane-permeate acetoxymethyl (AM) ester of fura 2 (Dojindo Laboratories, Kumamoto, Japan) dissolved in dimethyl sulfoxide (Dojindo Laboratories). The dye-loading methods used were as previously described (31) . Cultured neurons were washed with Hanks' balanced salt solution (HBSS) three times and loaded with 5 M fura 2-AM for 30 min at 37°C in a 5% CO 2 atmosphere incubator. After being washed with HBSS, cells were postincubated for 20 min. During Ca 2ϩ imaging recording, HBSS and drugs were continuously perfused at a rate of 2 ml/min. Fluorescent signals of fura 2-AM-loaded neurons were observed with a ϫ40 water-immersion objective and an FN1 upright microscope (Nikon, Tokyo, Japan). For fura 2 experiments the excitation light at 340 and 380 nm was provided by a monochromator (Cairn Research, Kent, UK) while the emission filter (510 nm) was placed in the filter wheel placed in front of the camera. Fluorescent images (F 340 and F380) were taken every 0.5 s using an iXON DU-897 cooled CCD camera (ANDOR, Belfast, UK). Data aquisition was controlled by MetaFluor software (Molecular Devices, Downingtown, PA).
Drugs. Unless otherwise noted, pharmacological reagents were obtained from Sigma-Aldrich. Hydrophobic compounds were dissolved in dimethyl sulfoxide at a concentration of 10 mM as a stock solution.
Data analysis. Image analysis was performed with MetaFluor and custom-made programs written in MATLAB (Math Works, Natick, MA). The cell field of interest was photographed using 380-nM fluorescent light. Fluorescence intensities from single cells excited at the two wavelengths (F 340 and F380) were recorded separately, and the fluorescence ratio: R ϭ F340/F380 was calculated after background subtraction (fluorescence of a cell-free area).
To ]i oscillations frequency and amplitude were calculated from the fixed windows (3-min recording) for the control and drug application. For the drug application, the 3-min recordings are corresponding to the time windows of the 3rd-5th min (early) or 8th-10th min (late) after drug application.
Statistical analysis. Statistical tests were performed using SigmaStat software (SPSS). Data are expressed as means Ϯ SE, and differences were considered significant at P Ͻ 0.05. Statistical differences in the frequency and amplitude data were determined by either one-way repeated measures or two-way ANOVA followed by post hoc comparisons with nicotine and nAChRs antagonists as factors. Previous studies indicate that extracellular Ca 2ϩ contributes to SCO (1, 21) . To determine the role of extracellular Ca 2ϩ on NCO in cultured cortical neurons, we examined the effects of EGTA, BAPTA-AM, and KCl. EGTA (10 mM) application completely abolished NCO in all cells recorded (P Ͻ 0.001, Fig. 1 , E, G, and H, n ϭ 21). BAPTA-AM (50 M) also blocked SCO and NCO (P Ͻ 0.001, n ϭ 32, data not shown). KCl (10 mM), a commonly used agent for membrane depolarization through activation of voltage-dependent Ca 2ϩ channel (VDCC), completely abolished [Ca 2ϩ ] i oscillations in all cells tested (P Ͻ 0.001, Fig. 1, F, G, and H, n ϭ 24) . These results confirm that extracellular Ca 2ϩ is required for NCO in cultured cortical neurons.
RESULTS
SCO
Roles of ␣ 4 ␤ 2 -nAChRs in NCO. The ␣ 4 ␤ 2 -and ␣ 7 -nAChRs are two subtypes of nAChRs, predominantly expressed in cortical neurons (11) . To determine the contribution of different nAChR subtypes to NCO, we tested the effect of the selective ␣ 4 ␤ 2 -nAChR antagonist dihydro-␤-erythroidine hydrobromide (DH␤E) and the ␣ 7 -nAChR antagonist methyllycaconitine citrate (MLA).
The nicotine-induced increase in both frequency and amplitude of the [Ca 2ϩ ] i oscillations was significantly reduced by DH␤E (200 nM) applied on top of nicotine ( Fig. 2A) . On average, the [Ca 2ϩ ] i oscillation frequency was 0.065 Ϯ 0.016, 0.179 Ϯ 0.011, and 0.089 Ϯ 0.014 Hz for control, nicotine, and nicotine ϩ DH␤E, respectively. Compared with nicotine, the frequency was significantly decreased in the presence of nicotine ϩ DH␤E (P Ͻ 0.01 vs. nicotine alone, n ϭ 82, Fig. 2B ] i oscillation amplitude was significantly decreased in the presence of nicotine ϩ DH␤E (P Ͻ 0.01, n ϭ 82, Fig. 2C ).
DH␤E (200 nM) itself decreased SCO frequency and prevented the nicotinic increase in frequency (P Ͻ Fig. 2, D and F) . Application of nicotine on top of DH␤E did not change the amplitude (P Ͼ 0.05, DH␤E 0.038 Ϯ 0.008 vs. 0.034 Ϯ 0.009 in Dh␤E ϩ nicotine, Fig. 2, E and F) .
To make sure that the ␣ 4 ␤ 2 -receptors were fully blocked, we also tested the effect of a higher concentration of DH␤E ( Compared with the control condition, *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001, 2-way ANOVA. DH␤E (1 M) also decreased the SCO frequency and prevented the nicotinic increase on the frequency (P Ͻ0.05, DH␤E 0.054 Ϯ 0.015 Hz vs. control 0.071 Ϯ 0.009 Hz; P Ͻ0.05 vs. DH␤E ϩ nicotine 0.060 Ϯ 0.010 Hz, n ϭ 64). DH␤E (1 M) also increased the SCO amplitude and prevented the nicotinic increase of the amplitude (P Ͻ 0.01, DH␤E 0.049 Ϯ 0.004 vs. control 0.023 Ϯ 0.003; P Ͼ 0.05 vs. Dh␤E ϩ nicotine 0.043 Ϯ 0.006, n ϭ 64). Thus, no difference in the effects of two concentrations of DH␤E on NCO or SCO was observed.
Two-way ANOVA of Ca 2ϩ oscillation frequency revealed the main effects of nicotine (P Ͻ 0.05), DH␤E (200 nM and 1 M) pretreatment (P Ͻ 0.001), and an interaction (P Ͻ 0.001). In the analysis of amplitude, two-way ANOVA revealed the main effects of nicotine (P Ͻ 0.01), DH␤E pretreatment (P Ͼ 0.05), and an interaction (P Ͻ 0.001).
These results indicate that DH␤E effectively blocked the nicotine-induced increase in [Ca 2ϩ ] i oscillation frequency and amplitude.
Role of ␣ 7 -nAChRs in NCO. We further tested the role of , n ϭ 78, Fig. 3, D and E) . MLA (20 nM) had no effect on the SCO amplitude but prevented the nicotinic increase in amplitude (P Ͼ 0.05, for the comparisons among control 0.022 Ϯ 0.001, MLA 0.022 Ϯ 0.001, and MLA ϩ nicotine 0.025 Ϯ 0.002, Fig. 4, D and F) . Two-way ANOVA of Ca 2ϩ oscillation amplitude revealed the main effects of nicotine (P Ͻ 0.001), MLA pretreatment (P Ͼ 0.05), and an interaction (P Ͻ 0.01). In the analysis of frequency, twoway ANOVA revealed the main effects of nicotine (P Ͻ 0.01), MLA pretreatment (P Ͻ 0.01), and an interaction (P Ͻ 0.05).
Application of a higher concentration of MLA (200 nM) had no effect on SCO frequency but also prevented the nicotinic increase in the main effects of nicotine (P Ͻ 0.001), MLA pretreatment (P Ͼ 0.05), and an interaction (P Ͼ 0.05). In the analysis of frequency, two-way ANOVA revealed the main effects of nicotine (P Ͻ 0.001), MLA pretreatment (P Ͻ 0.01), and an interaction (P Ͻ 0.01).
Thus, pretreatment with MLA effectively blocked the nicotine-induced increase in [Ca 2ϩ ] i oscillation frequency at either concentration, but blocked the amplitude only at low concentration. Posttreatment with MLA significantly reduced the nicotine-induced increase in [Ca 2ϩ ] i oscillation frequency and amplitude only at a low concentration.
Roles of simultaneous blockage of ␣ 4 ␤ 2 -and ␣ 7 -nAChRs on nicotine-induced Ca 2ϩ oscillation. The effect of coapplication of DH␤E (200 nM) and MLA (200 nM) on NCO was tested. DH␤E and MLA decreased the SCO frequency (P Ͻ 0.05, Dh␤E ϩ MLA 0.056 Ϯ 0.008 Hz vs. control 0.081 Ϯ 0.009 Hz, n ϭ 86, Fig. 5, A and B) , and application of nicotine caused a further decrease in the frequency without statistical significance (P Ͼ 0.05, Dh␤E ϩ MLA ϩ nicotine 0.039 Ϯ 0.008 Hz vs. Dh␤E ϩ MLA 0.056 Ϯ 0.008 Hz, n ϭ 86, Fig. 5, A and B) .
DH␤E and MLA increased the SCO amplitude (P Ͻ 0.05, Dh␤E ϩ MLA 0.028 Ϯ 0.003 vs. control 0.016 Ϯ 0.003, n ϭ 86, Fig. 5, A and C) . Further application of nicotine significantly decreased the amplitude (Dh␤E ϩ MLA ϩ nicotine 0.014 Ϯ 0.002 vs. Dh␤E ϩ MLA 0.028 Ϯ 0.003, P Ͻ 0.05, n ϭ 86, Fig. 5, A and C) .
Thus, coapplication of Dh␤E ϩ MLA fully blocked the nicotinic increase in [Ca 2ϩ ] i oscillations.
DISCUSSION
In this study, we found that SCO occurred in cortical neurons cultured for 7-10 days in vitro. This is in agreement with previous studies that showed cortical neurons cultured from rat embryos are able to develop mature networks within a few days in vitro and generate SCO (21) . nAChRs are widely expressed in cortical networks and modulate synaptic transmission and plasticity. A low concentration of nicotine enhanced the frequency and amplitude of [Ca 2ϩ ] i oscillations in this study. To our knowledge this is the first report that nicotine induced [Ca 2ϩ ] i oscillations in cultured cortical neurons. Although in cultured pinealocytes nicotine induced [Ca 2ϩ ] i oscillations, these oscillations occurred under the condition of nicotine withdrawal in a concentration-dependent manner (17) .
The possible mechanisms for nicotine-induced [Ca 2ϩ ] i oscillation may involve Ca 2ϩ influx through nAChR activation or through VDCC opening, which was caused by the nAChRmediated depolarization and/or the Ca 2ϩ release from the endoplasmic reticulum (9, 23) .
A high concentration of ACh or nicotine inhibited synchronized [Ca 2ϩ ] i oscillations in rat cultured cortical neurons (27) , which is different from our results that nicotine enhanced [Ca 2ϩ ] i oscillations at a low concentration. The difference between our results and the above report is likely related to the desensitization of nicotine receptors induced by agonist at high concentration. Another reason for the nicotinic inhibition on [Ca 2ϩ ] i oscillations at high concentration may be related to the strong activation of NMDAR induced by nicotine, since our previous data show nicotine at high concentration (100 M) inhibited the neuronal network ␥-oscillation, which can be blocked by NMDAR antagonist (32) .
DH␤E pretreatment decreased the SCO frequency, indicative of the activation of ␣ 4 ␤ 2 -nAChRs by endogenously released ACh during SCO, which may be supported by the abundant expression of ␣ 4 ␤ 2 -nAChRs at glutamatergic and GABAergic presynaptic terminals that modulated glutamate and GABA release, critical for the [Ca 2ϩ ] i oscillations (8, 9, 33) . Interestingly, DH␤E itself increased SCO amplitude, which may be explained by the finding that DH␤E enhanced the [Ca 2ϩ ] i response in MSDB neurons (31) and is in agreement with the evidence that DH␤E increased P20 amplitude on event-related ␥-activity (7). DH␤E decreased SCO frequency but increased amplitude; MLA reduced SCO frequency but had no effect on the amplitude. These results indicate that both nAChR subtypes are likely involved in SCO generation and that there is a differential modulation of nAChRs on the frequency and amplitude of SCO. The differential modulation of nAChR subtypes on the frequency and amplitude of [Ca 2ϩ ] i oscillations supported the notion that the frequency and amplitude of [Ca 2ϩ ] i oscillations encode different information contained in the Ca 2ϩ signal (2, 29) . Albeit the different effects of DH␤E on the frequency and amplitude of SCO, DH␤E pretreatment prevented the nicotinic increment of frequency and the amplitude of [Ca 2ϩ ] i oscillations, suggesting that ␣ 4 ␤ 2 -nAChRs play a critical role in both SCO and NCO.
MLA (20 nM) is able to block NCO frequency and amplitude, suggesting that ␣ 7 -nAChR is vital for NCO. However, MLA (200 nM) did not affect NCO amplitude, although it prevented the nicotinic increase in [Ca 2ϩ ] i oscillation frequency. It was reported that MLA, at concentration Ն40 nM, may interact with non-␣ 7 -nAChR (␣ 4 ␤ 2 -nAChR) and lead to ␣ 4 ␤ 2 -nAChR activation, which may mask MLA's blocking effect on ␣ 7 -nAChR (18) . This hypothesis was conformed by our experiments that showed 20 nM MLA effectively blocked NCO.
The similar role between coapplication of MLA ϩ DH␤E and DH␤E alone on SCO (the decreased frequency but the increased amplitude) can be explained by a major role of DH␤E on SCO.
Interestingly, coapplication of MLA ϩ DH␤E reversed the role of nicotine on the [Ca 2ϩ ] i oscillations (both frequency and amplitude), suggestive of the contribution of both ␣ 4 ␤ 2 -and ␣ 7 -nAChRs to NCO. This observation is similar to the previous report of Wang et al. (31) that showed that, in the presence of both ␣ 4 ␤ 2 -and ␣ 7 -nAChR antagonists, nicotinic enhancement of ␥-oscillation was reversed in the rat hippocampal slices, suggesting that a complicated mechanism, yet unknown, was involved in such a reversal.
In conclusion, nicotine modulates [Ca 2ϩ ] i oscillations via both ␣ 4 ␤ 2 -and ␣ 7 -nAChRs activation; and two nAChR subtypes were differentially involved in the modulation of SCO. 
